ClinConnect ClinConnect Logo
Search / Trial NCT05968053

Detection of Microplastics and Nanoplastics in Neurosurgery Patients (DT-MiNi)

Launched by BEIJING TIANTAN HOSPITAL · Jul 23, 2023

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Microplastics Nanoplastics Intracranial Aneurysm Brain Tumor Carotid Artery Stenosis

ClinConnect Summary

The clinical trial titled "Detection of Microplastics and Nanoplastics in Neurosurgery Patients" is exploring whether tiny plastic particles, which are commonly found in our environment and food, can also be present in the bodies of patients undergoing neurosurgery. These particles, known as microplastics and nanoplastics, could potentially be found in samples such as blood, brain tissue, and tumors during surgery. The study aims to collect these samples from neurosurgery patients to determine if these plastic particles exist in their bodies, helping us understand the impact of plastic pollution on human health.

To be eligible for this study, participants must be between 18 and 80 years old and scheduled for any type of neurosurgery. If you decide to participate, you’ll be asked to provide biological samples during your surgery. The findings from this research could provide valuable insights into how plastic pollution affects patients and may help guide future health recommendations. It's important to note that participation is completely voluntary, and you can choose not to take part at any time.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age 18-80 years
  • Any type of neurosurgery
  • Exclusion Criteria:
  • ·refusal of the patient to participate

About Beijing Tiantan Hospital

Beijing Tiantan Hospital, affiliated with Capital Medical University, is a leading medical institution in China renowned for its expertise in neurology, neurosurgery, and various other specialties. As a prominent clinical trial sponsor, the hospital is committed to advancing medical research and improving patient outcomes through innovative studies. With a focus on high-quality clinical trials, Beijing Tiantan Hospital adheres to rigorous ethical standards and regulatory requirements, fostering collaboration with academic institutions and industry partners to facilitate the development of cutting-edge therapies and interventions. Its state-of-the-art facilities and experienced research team enable the hospital to play a pivotal role in the global medical research landscape.

Locations

Beijing, Beijing, China

Patients applied

0 patients applied

Trial Officials

Runting Li, MD

Principal Investigator

Beijing Tiantan Hospital

Yitong Jia, MD

Principal Investigator

Beijing Tiantan Hospital

Ke Wang, MD

Principal Investigator

Beijing Tiantan Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported